Please assess the completion status of the following clinical trial:

Trial Title: Treatment of Parkinson Disease and Multiple System Atrophy Using Intranasal Insulin.

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. Males or females older than 17 years.~2. Clinical diagnosis of Parkinson disease or multiple system atrophy.~3. Provide written informed consent to participate in the study.~4. Understand that they may withdraw their consent at any time.~Exclusion Criteria:~1. Women who are pregnant or lactating.~2. In the investigator's opinion, have significant systemic, hepatic, cardiovascular, renal or other illness that can interfere based on investigator judgment with the trial.~3. History of dementia.~4. Unable to walk without help for at least 1 minute.~5. History of allergic reaction to insulin.~6. The presence of inflammation of nasal cavity that may prevents absorption of insulin.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Insulin (Type: EXPERIMENTAL): 40 IU of intranasal insulin daily
- Placebo (Type: PLACEBO_COMPARATOR): Placebo arm using intranasal normal saline

Based on this trial design, predict the completion outcome and termination type (if applicable).